(Q38782254)

6 September 2017

1,25 dihydroxyvitamin D3 inhibits the proliferation of thyroid cancer stem-like cells via cell cycle arrest (English)

1 reference

6 September 2017

1 reference

Wen Peng

1

1 reference

6 September 2017

Kun Wang

series ordinal

2

1 reference

6 September 2017

Rendong Zheng

series ordinal

3

1 reference

6 September 2017

Michael Derwahl

series ordinal

4

1 reference

6 September 2017

30 March 2016

1 reference

6 September 2017

1 reference

6 September 2017

41

1 reference

6 September 2017

2

1 reference

6 September 2017

71-80

1 reference

The role of vitamin D in reducing cancer risk and progression

6 September 2017

1 reference

https://api.crossref.org/works/10.3109%2F07435800.2015.1037048

Ecological studies of ultraviolet B, vitamin D and cancer since 2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07435800.2015.1037048

Decreased 1-25 dihydroxyvitamin D3 concentration in peripheral blood serum of patients with thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07435800.2015.1037048

Effect of 22-oxa-1,25-dihydroxyvitamin D3 on human thyroid cancer cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07435800.2015.1037048

Vitamin D arrests thyroid carcinoma cell growth and induces p27 dephosphorylation and accumulation through PTEN/akt-dependent and -independent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07435800.2015.1037048

Thyroid cancer resistance to vitamin D receptor activation is associated with 24-hydroxylase levels but not the ff FokI polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07435800.2015.1037048

1,25-dihydroxyvitamin D3 and a superagonistic analog in combination with paclitaxel or suberoylanilide hydroxamic acid have potent antiproliferative effects on anaplastic thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07435800.2015.1037048

Gene expression of vitamin D metabolic enzymes at baseline and in response to vitamin D treatment in thyroid cancer cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07435800.2015.1037048

Vitamin D: considerations in the continued development as an agent for cancer prevention and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07435800.2015.1037048

Anaplastic thyroid carcinoma: biology, pathogenesis, prognostic factors, and treatment approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07435800.2015.1037048

Identifying thyroid stem/progenitor cells: advances and limitations.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07435800.2015.1037048

Characterization of side population in thyroid cancer cell lines: cancer stem-like cells are enriched partly but not exclusively.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07435800.2015.1037048

In vitro identification and characterization of CD133(pos) cancer stem-like cells in anaplastic thyroid carcinoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07435800.2015.1037048

CD133+ anaplastic thyroid cancer cells initiate tumors in immunodeficient mice and are regulated by thyrotropin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07435800.2015.1037048

Thyroid stem cells and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07435800.2015.1037048

Insulin receptor isoforms and insulin-like growth factor receptor in human follicular cell precursors from papillary thyroid cancer and normal thyroid.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07435800.2015.1037048

Tumorigenic and metastatic activity of human thyroid cancer stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07435800.2015.1037048

Metformin inhibits growth of thyroid carcinoma cells, suppresses self-renewal of derived cancer stem cells, and potentiates the effect of chemotherapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07435800.2015.1037048

Deoxyribonucleic acid profiling analysis of 40 human thyroid cancer cell lines reveals cross-contamination resulting in cell line redundancy and misidentification

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07435800.2015.1037048

Stem cells derived from goiters in adults form spheres in response to intense growth stimulation and require thyrotropin for differentiation into thyrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07435800.2015.1037048

Oestrogen action on thyroid progenitor cells: relevant for the pathogenesis of thyroid nodules?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07435800.2015.1037048

Excessive activation of tyrosine kinases leads to inhibition of proliferation in a thyroid carcinoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07435800.2015.1037048

Expression of endoderm stem cell markers: evidence for the presence of adult stem cells in human thyroid glands

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07435800.2015.1037048

Medullary thyroid carcinoma cell lines contain a self-renewing CD133+ population that is dependent on ret proto-oncogene activity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07435800.2015.1037048

Identification of an adult stem/progenitor cell-like population in the human thyroid

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07435800.2015.1037048

Interleukin-1α mediates the antiproliferative effects of 1,25-dihydroxyvitamin D3 in prostate progenitor/stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07435800.2015.1037048

1,25(OH)2vitamin D3 inhibits cell proliferation by promoting cell cycle arrest without inducing apoptosis and modifies cell morphology of mesenchymal multipotent cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07435800.2015.1037048

Tumour stem cells and drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07435800.2015.1037048

Mechanisms controlling pathogenesis and survival of leukemic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07435800.2015.1037048

Vitamin D and differentiation in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07435800.2015.1037048

Induction of sodium iodide symporter gene and molecular characterisation of HNF3 beta/FoxA2, TTF-1 and C/EBP beta in thyroid carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07435800.2015.1037048

Effects of BMP-2 and vitamin D3 on the osteogenic differentiation of adipose stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07435800.2015.1037048

Platelet-rich plasma and 1,25(OH)2 vitamin D3 synergistically stimulate osteogenic differentiation of adult human mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07435800.2015.1037048

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07435800.2015.1037048

GADD45gamma: a new vitamin D-regulated gene that is antiproliferative in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07435800.2015.1037048

1,25 dihydroxyvitamin D-mediated orchestration of anticancer, transcript-level effects in the immortalized, non-transformed prostate epithelial cell line, RWPE1.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07435800.2015.1037048

10.3109/07435800.2015.1037048

21 January 2018

Identifiers

DOI

1 reference

6 September 2017

1 reference